[CH2:1]([N:4]([C@H:14]1[CH2:23][CH2:22][C:21]2[C:16](=[CH:17][CH:18]=[CH:19][C:20]=2[O:24][CH3:25])[CH2:15]1)[C:5](=[O:13])[CH2:6][CH2:7][CH2:8][CH2:9][C:10]([OH:12])=[O:11])[CH2:2][CH3:3].C(N[C@H]1CCC2C(=CC=C[C:36]=2[O:40]C)C1)CC>>[CH2:1]([N:4]([C@H:14]1[CH2:23][CH2:22][C:21]2[C:16](=[CH:17][CH:18]=[C:19]([O:40][CH3:36])[C:20]=2[O:24][CH3:25])[CH2:15]1)[C:5](=[O:13])[CH2:6][CH2:7][CH2:8][CH2:9][C:10]([OH:12])=[O:11])[CH2:2][CH3:3](S)-N-propyl-N-[5-methoxy-1,2,3,4-tetrahydro-2-naphthyl]-5-carboxypentanamide (Intermediate 31) starting from (S)-N-propyl-5-methoxy-1,2,3,4-tetrahydro-2-naphthylamine, prepared as described in J. Med. Chem., 29, 912 (1986).
Wird geladen…